Cell Line Development Companies

Cell line development market size exceeded usd 4 2 billion in 2019 and is set to grow at around 12 5 cagr between 2020 and 2026.

Cell line development companies.

Selexis sa a jsr life sciences company is the global leader in cell line development with best in class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover develop and commercialize innovative medicines and vaccines. These cell lines are used in production of vaccines antibodies artificial tissues and synthesis of biological components. Because of this we can now develop cell lines in less than 5 months. Generate master and working cell banks cell line selection cell line quality assessment cell line characterization.

Early on in our development of the choexpress and hekexpress 293 systems we were able to identify highly stable and robust cell lines for transfection production and scale up. Cell line development and assurance of monoclonality are critical steps in the process of generating biopharmaceutical molecules such as monoclonal antibodies. Cell line development company ology bio offers mammalian cell line development capabilities and can work with most commercial recombinant mammalian cell lines to assist partners with final cell line selection comparability assessments and cell line characterization. The cell lines are used to study biological processes and retain stability of the formed tissues.

Based on the suretechnology platform and unique world class expertise selexis sure cell line development services significantly reduce the time effort and costs that are associated with the development of high performance mammalian cell lines for therapeutic protein production e g development of monoclonal antibodies bi specific monoclonal antibodies growth factors and enzymes.